1476
Vol. 54, No. 10
tained from T. ophiraphidites.
(22E,24S)-24-Isopropenylcholesta-5,22-dien-3b-ol
(1b) Compound
6b (52 mg, 118 mmol) was converted to 1b (43 mg, 87%) according to the
Experimental
procedure described above for the conversion of 6a to 1a. 1b: white needles,
General Melting points were determined by a Yazawa BY-1 hot-stage mp 174—176 °C. [a]D25 ꢁ46.3° (cꢀ2.07, CHCl3). H-NMR data: see Table
1
apparatus and are uncorrected. Optical rotations were measured with a
1. 13C-NMR data: see Table 2. Anal. Calcd for C30H48O: C, 84.84; H, 11.39.
1
JASCO DIP-360 polarimeter. H- and 13C-NMR spectra were recorded on a Found: C, 84.92; H, 11.69.
Bruker DRX500 (500 MHz for 1H and 125 MHz for 13C) or JEOL JNM-
(24S)-24-Isopropenyl-6b-methoxy-3a,5a-cyclocholestane (7a) A so-
LA400 (400 MHz for 1H and 100 MHz for 13C) spectrometer in CDCl3 solu- lution of 5a (37.5 mg, 82.1 mmol) in AcOEt (1.0 ml) was hydrogenated in the
tion. CDCl3 signal was used as a reference (d 77.0) for 13C-chemical shifts. presence of 10% Pd/C (15 mg) overnight. The catalyst was filtered off
EI-MS (70 eV) and HR-EI-MS spectra were obtained on a JEOL JMS-700 through a pad of Celite and the filtrate was concentrated in vacuo. The
1
spectrometer. A part of H-NMR data, d: 0.44 (dd, Jꢀ8.0, 5.1 Hz, 4a-H),
0.65 (t, Jꢀ4.4 Hz, 4b-H), 2.78 (br t, Jꢀ2.7 Hz, 6-H), 3.32 (s, OMe), for
compounds with a 6b-methoxy-3a,5-cyclo structure are not described, since
they were common to all such compounds.
residue was chromatographed on silica gel with hexane–ether (20 : 1) to give
the hydrogenated product (37 mg, 81.3 mmol) as an oil.
2-Nitrophenyl selenocyanate (55 mg, 244 mmol) and n-tributylphosphine
(61 ml, 244 mmol) were added to a solution of the hydrogenated product
(37 mg, 81.3 mmol) in THF (2.0 ml) and the mixture was stirred for 1 h
(22E,24R)-24-Isopropenyl-6b-methoxy-3a,5-cyclo-5a-cholest-22-ene
(6a) A solution of 22R-alcohol 3a1,3) (70 mg, 169 mmol) (1H-NMR d: 4.12 under N2. 30% H2O2 (1.0 ml) was added and the mixture was stirred for an-
(dd, Jꢀ7.4, 3.4 Hz, 22-H)), triethyl orthopropionate (100 ml, 507 mmol) and other 1 h. The mixture was diluted with ether and brine. The organic phase
propionic acid (7.5 ml, 101 mmol) in xylene (2.1 ml) was heated at reflux was washed with saturated aqueous NaHCO3 and brine, dried over Na2SO4,
under N2 for 1 h. After removal of most of the solvent on a rotary evaporator, and concentrated in vacuo. The residue was chromatographed on silica gel
the residue was chromatographed on silica gel with hexane–ether (20 : 1) to
1
with hexane–ether (20 : 1) to give 7a (22 mg, 60%, 2 steps) as oil. H-NMR
1
give the rearranged product 4a (71 mg) as oil. H-NMR d: 0.707/0.718 (s, d: 0.70 (s, 18-H3), 0.80 (d, Jꢀ6.1 Hz, 26-H3), 0.91 (d, Jꢀ6.1 Hz, 27-H3),
18-H3), 1.224/1.243 (t, Jꢀ7.1 Hz, OCH2CH3), 4.02—4.16 (m, OCH2CH3), 0.92 (d, Jꢀ6.6 Hz, 21-H3), 1.02 (s, 19-H3), 1.56 (s, 30-H3), 4.60 (br s, 29-
4.94—5.29 (m, 22-H, 23-H). 13C-NMR d: 59.91/59.98 (C-29),
124.53/125.20 (C-23), 140.31/141.17 (C-22), 176.21/176.74 (CꢀO).
LiAlH4 (16 mg, 142 mmol) was added to a solution of 4a (71 mg) at 0 °C
under N2 and the mixture was stirred for 30 min. The solution was diluted
Hb), 4.74 (br s, 29-Hb). 13C-NMR d: 12.20, 13.05, 18.88, 18.90, 19.29,
20.85, 21.48, 21.52, 22.77, 24.17, 24.96, 26.30, 28.24, 30.23, 30.46, 33.34,
34.15, 35.04, 35.28, 36.24, 40.24, 42.73, 43.37, 48.02, 55.50, 56.06, 56.50,
56.55, 82.43, 111.86, 147.37. HR-EI-MS m/z 440.4062 [Mꢂ]; C31H52O re-
with moist ether and then a small amount of water. The supernatant solution quires 440.4018.
was filtered through a pad of Celite and concentrated in vacuo. The residue
(24S)-24-Isopropenylcholest-5-en-3b-ol (2a) A solution of 7a (22 mg,
was chromatographed on silica gel with hexane–AcOEt (10 : 1) to give 5a 49.2 mmol) in dioxane (0.60 ml) and H2O (0.20 ml) containing p-TsOH·H2O
1
(48 mg, 105 mmol) as oil. H-NMR d: 0.73 (s, 18-H3), 3.33—3.65 (m, 29- (374 mg, 1.97 mmol) was heated at 105 °C for 2 h. Extractive (ether) work-up
H2), 5.05—5.27 (m, 22-H, 23-H). 13C-NMR d: 67.17/67.57 (C-29),
126.56/126.70 (C-23), 139.70/140.16 (C-22).
gave a crude product which was chromatographed on silica gel with
hexane–AcOEt (7 : 1) to give 2a as a solid. Recrystallization from MeOH af-
forded 2a (12 mg, 67%) as white plates, mp 134—135 °C. [a]D25 ꢁ37.6°
2-Nitrophenyl selenocyanate (71.5 mg, 315 mmol) and tri-n-butylphos-
phine (79 ml, 315 mmol) were added to a solution of 5a (48 mg, 105 mmol)
in THF (2.5 ml) and the mixture was stirred for 1 h under N2. 30% H2O2 Anal. Calcd for C30H50O: C, 84.44; H, 11.81. Found: C, 84.36; H, 12.01.
1
(cꢀ1.29, CHCl3). H-NMR data: see Table 3. 13C-NMR data: see Table 2.
(1.0 ml) was added and the mixture was stirred for another 1.5 h. The mix-
ture was diluted with ether and brine, and the organic layer was washed with Compound 5b (26 mg, 56.7 mmol) was converted to 7b (14 mg, 58%, 2
saturated aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated
(24R)-24-Isopropenyl-6b-methoxy-3a,5-cyclo-5a-cholestane
(7b)
steps) according to the procedure described for 5a. 7b: oil. 1H-NMR d: 0.71
in vacuo. The residue was chromatographed on silica gel with hexane–ether (s, 18-H3), 0.80 (d, Jꢀ6.3 Hz, 26-H3), 0.90 (d, Jꢀ6.6 Hz, 27-H3), 0.91 (d,
1
(20 : 1) to give 6a (38 mg, 51%, 3 steps) as oil. H-NMR d: 0.73 (s, 18-H3), Jꢀ6.5 Hz, 21-H3), 1.02 (s, 19-H3), 1.56 (s, 30-H3), 4.61 (br s, 29-Ha), 4.74
0.82 (d, Jꢀ6.6 Hz, 26-H3), 0.83 (d, Jꢀ6.6 Hz, 27-H3), 1.02 (d, Jꢀ6.4 Hz, 21-
(br s, 29-Hb). 13C-NMR d: 12.23, 13.04, 18.51, 18.56, 19.30, 20.85, 21.51,
H3), 1.02 (s, 19-H3), 1.65 (s, 30-H3), 2.19 (m, 25-H), 4.66 (br s, 29-Ha), 4.68
21.62, 22.77, 24.17, 24.96, 26.26, 28.27, 30.23, 30.46, 33.33, 33.92, 35.00,
(br s, 29-Hb), 5.24 (m, 22-H, 23-H). 13C-NMR d: 12.42, 13.06, 19.29, 20.13, 35.29, 35.54, 40.28, 42.77, 43.37, 47.99, 55.04, 56.35, 56.50, 56.55, 82.42,
20.34, 20.74, 21.19, 21.44, 22.74, 24.19, 24.95, 28.55, 29.15, 30.46, 33.33, 112.30, 147.10. HR-EI-MS m/z 440.4038 [Mꢂ]; C31H52O requires 440.4018.
35.05, 35.23, 40.14, 40.19, 42.71, 43.37, 48.04, 56.26, 56.54, 58.43, 82.39,
110.09, 128.48, 137.82, 148.24. Anal. Calcd for C31H50O: C, 84.87; H, 31.8 mmol) was converted to 2b (10 mg, 74%) in the same manner as de-
(24R)-24-Isopropenylcholest-5-en-3b-ol (2b) Compound 7b (14 mg,
11.49. Found: C, 84.58; H, 11.51.
(22E,24R)-24-Isopropenylcholesta-5,22-dien-3b-ol (1a) A solution of
6a (37 mg, 84 mmol) in dioxane (1.2 ml) and H2O (0.40 ml) containing p- see Table 2. Anal. Calcd for C30H50O: C, 84.44; H, 11.81. Found: C, 84.18;
TsOH·H2O (64 mg, 3.4 mmol) was heated at 105 °C for 3 h. Extractive H, 11.86.
(ether) work-up gave a crude product which was chromatographed on silica
scribed for the conversion of 6a to 1a. 2b: white needles; mp 139—140 °C.
[a]D25 ꢁ37.8° (cꢀ0.98, CHCl3). H-NMR data: see Table 3. 13C-NMR data:
1
gel with hexane–AcOEt (7 : 1) to give 1a as a solid. Recrystallization from
MeOH afforded 1a (24 mg, 67%) as white plates, mp 150—152 °C. [a]D25
ꢁ41.7° (cꢀ2.59, CHCl3). 1H-NMR data: see Table 1. 13C-NMR data: see
Table 2. Anal. Calcd for C30H48O: C, 84.84; H, 11.39. Found: C, 84.76; H,
11.41.
Acknowledgments This work was supported in part by a Grant from
Colciencias to C. D.
References and Notes
1) Calderon G. J., Castellanos L., Duque C., Echigo S., Hara N., Fuji-
moto Y., Steroids, 69, 93—100 (2004).
2) Echigo S., Calderon G. J., Castellanos L., Duque C., Hara N., Fuji-
moto Y., Steroids, 72 (2007), in press.
3) Wiersig J. R., Waespe-Sarcevic N., Djerassi C., J. Org. Chem., 44,
3374—3382 (1979).
(22E,24S)-24-Isopropenyl-6b-methoxy-3a,5-cyclo-5a-cholest-22-ene
(6b) (22S)-Alcohol 3b1,3) (131 mg, 316 mmol) (1H-NMR d: 4.21 (br t,
Jꢀ5.2 Hz, 22-H)) was converted to 6b (59 mg, 42%, 3 steps) according to
the procedure described for 3a. The intermediate 4b: oil, 1H-NMR d:
0.710/0.717 (s, 18-H3), 1.232/1.244 (t, Jꢀ7.1 Hz, OCH2CH3), 3.99—4.15
(m, OCH2CH3), 4.96—5.25 (m, 22-H, 23-H). 13C-NMR d: 59.80/59.97 (C-
29), 124.80/125.17 (C-22), 140.35/141.03 (C-23), 176.18/176.61 (CꢀO).
5b: oil, 1H-NMR d: 0.72 (s, 18-H3), 3.36—3.63 (m, 29-H2), 5.04—5.26 (m,
22-H, 23-H), 13C-NMR d: 67.16/67.47 (C-29), 126.78/126.90 (C-23),
139.65/140.00 (C-22). 6b: mp 116—117 °C (recrystallized from MeOH),
1H-NMR d: 0.73 (s, 18-H3), 0.82 (d, Jꢀ6.6 Hz, 26-H3), 0.84 (d, Jꢀ6.6 Hz,
27-H3), 1.00 (d, Jꢀ6.6 Hz, 21-H3), 1.02 (s, 19-H3), 1.65 (s, 30-H3), 2.18 (m,
25-H), 4.66 (br s, 29-Ha), 4.68 (br s, 29-Hb), 5.23 (m, 22-H, 23-H), 13C-
NMR d: 12.41, 13.07, 19.28, 20.20, 20.50, 20.78, 21.29, 21.43, 22.74,
24.28, 24.95, 29.02, 29.29, 30.46, 33.33, 35.06, 35.22, 40.15, 40.38, 42.68,
43.37, 48.03, 56.04, 56.55, 56.59, 58.59, 82.39, 110.06, 128.64, 137.86,
148.36. Anal. Calcd for C31H50O: C, 84.87; H, 11.49. Found: C, 84.58; H,
11.51.
4) Sucrow W., Schubert B., Richter W., Slopianka M., Chem. Ber., 104,
3689—3703 (1971).
5) Khripach V. A., Zhabinskii V. N., Konstantinova O. V., Khripach N. B.,
Antonchick A. P., Schneider B., Steroids, 67, 597—603 (2002).
6) Wright J. L. C., McInnes A. G., Shimizu S., Smith D. G., Walter J. A.,
Idler D., Khalil W., Can. J. Chem., 56, 1898—1903 (1978).
7) Kikuchi T., Kadota S., Suehara H., Namba T., Chem. Pharm. Bull., 33,
2235—2242 (1985).
8) Tam Ha T. B., Kokke W. C. M. C., Proudfoot J. R., Djerassi C.,
Steroids, 45, 263—276 (1985).
9) Kadota S., Sima T., Kikuchi T., Chem. Pharm. Bull., 35, 200—210
(1987).
10) Catalan C. A. N., Thompson J. E., Kokke W. C. M. C., Djerassi C.,